Home Biosimilar Antibodies Immunology & Inflammation Interleukins antibody Tralokinumab (Anti-IL-13) For research use only.
Not for use in humans.

Tralokinumab (Anti-IL-13)

Synonyms: null

Tralokinumab (Anti-IL-13) is a fully human IgG4 monoclonal antibody specifically targeting IL-13 with high affinity. It can be used for the research of the atopic dermatitis (AD). MW :145.5 KD.

Tralokinumab (Anti-IL-13)

Purity & Quality Control

Batch: A245301 Purity: 99% Protein concentration: 12.97mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective Interleukins Inhibitors

Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Tralokinumab (Anti-IL-13) is a fully human IgG4 monoclonal antibody specifically targeting IL-13 with high affinity. It can be used for the research of the atopic dermatitis (AD). MW :145.5 KD.

Product Details

CAS No. 1044515-88-9
Molecular Weight 145.5 kDa
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Tralokinumab (Anti-IL-13) | Tralokinumab (Anti-IL-13) supplier | purchase Tralokinumab (Anti-IL-13) | Tralokinumab (Anti-IL-13) cost | Tralokinumab (Anti-IL-13) manufacturer | order Tralokinumab (Anti-IL-13) | Tralokinumab (Anti-IL-13) distributor